LI
GSK icon

LRI Investments’s GSK GSK Stock Holding History

LRI Investments’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.7K Sell
1,216
-1,134
-48% -$60K 0.01% 523
2026
Q1 		$130K Buy
2,350
+288
+14% +$15.6K 0.01% 366
2025
Q4 		$101K Sell
2,062
-76
-4% -$3.54K 0.01% 419
2025
Q3 		$92.3K Hold
2,138
– – 0.01% 432
2025
Q2 		$82.1K Sell
2,138
-424
-17% -$16.2K 0.01% 468
2025
Q1 		$99.3K Hold
2,562
– – 0.01% 421
2024
Q4 		$86.6K Hold
2,562
– – 0.01% 438
2024
Q3 		$88.1K Buy
2,562
+524
+26% +$21.4K 0.01% 435
2024
Q2 		$78.5K Buy
2,038
+1,639
+411% +$68.9K 0.01% 424
2024
Q1 		$17.1K Buy
+399
New +$16.5K ﹤0.01% 403

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

LRI Investments's GSK Position: Q2 2026 in Review

LRI Investments reduced its GSK (GSK) stake by 48% in Q2 2026, selling an estimated $60K and leaving 1,216 shares worth $63.7K. The position accounts for 0.01% of the portfolio, ranked #523.

LRI Investments first reported a position in GSK in Q1 2024 and has held it in 10 quarters since. The position peaked at $130K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • LRI Investments held 1,216 shares of GSK worth $63.7K as of Q2 2026.
  • LRI Investments sold 1,134 GSK shares in Q2 2026, an estimated $60K.
  • GSK made up 0.01% of LRI Investments's portfolio in Q2 2026, its #523 holding.
  • LRI Investments first reported a position in GSK in Q1 2024 and has held it in 10 quarters since.
  • LRI Investments's GSK position peaked at $130K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.